Enterprise League logo
JenaValve Technology, Inc. Logo

JenaValve Technology, Inc.

Irvine, United States (US) · Health and Medical

Do you work at JenaValve Technology, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

JenaValve Technology is an Irvine, California-based medical device company pioneering the field of transcatheter aortic valve replacement (TAVR) for aortic regurgitation (AR).We develop and manufacture the Trilogy® Transcatheter Heart Valve System, the first and only FDA-approved TAVR device specifically designed for this challenging condition.JenaValve’s innovative approach utilizes locator technology to ensure precise valve alignment and secure anchoring, offering a minimally invasive treatment option for high-risk patients who may not be suitable for traditional open-heart surgery.

Overview

JenaValve Technology is an Irvine, California-based medical device company pioneering the field of transcatheter aortic valve replacement (TAVR) for aortic regurgitation (AR).

We develop and manufacture the Trilogy® Transcatheter Heart Valve System, the first and only FDA-approved TAVR device specifically designed for this challenging condition.

JenaValve’s innovative approach utilizes locator technology to ensure precise valve alignment and secure anchoring, offering a minimally invasive treatment option for high-risk patients who may not be suitable for traditional open-heart surgery. Our commitment to patient safety and efficacy is at the heart of everything we do.

With a strong clinical trial program, including the ALIGN-AR IDE Clinical Trial, and a growing global presence, JenaValve is dedicated to improving the lives of patients worldwide suffering from AR. We are a team of dedicated engineers, scientists, and clinicians committed to advancing cardiac care.
Visit Official Website

Most teams do this before shortlisting


Contact Details

+11-949-767-2110
reimbursement.usa@jenavalve.com

Irvine, United States (US), 4 Cromwell

Founded

2013

Company Type

Private Limited Company

Employees

150-200

Categories

Medical Technology Solutions
Manufacturing
Medical Equipment and Services

Awards

• 2026 OpenSee all

Products

Default Product Image
Trilogy Transcatheter Heart Valve System
Medical Equipment and Services

The Trilogy® Transcatheter Heart Valve System is the first and only FDA-approved TAVR system specifically indicated for the treatment of symptomatic, severe native tricuspid aortic valve regurgitation (not due to acute endocarditis, rheumatic heart disease, or acute aortic dissection) in patients who are judged by a Heart Team, including a cardiac surgeon, to be at high or greater risk for surgical aortic valve replacement (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

N/A

Companies teams usually look at after JenaValve Technology, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.